Perspectives on benefit-risk decision-making in vaccinology: Conference report

References

• Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331(12):778-84; PMID:8065407; http://dx.doi.org/10.1056/NEJM199409223311206
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123(7):518-27; PMID:7661497; http://dx.doi.org/10.7326/0003-4819-123-7-199510010-00008
   PubMed Web of Science ®Google Scholar
• Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20(13–14):1831-6; PMID:11906772; http://dx.doi.org/10.1016/S0264-410X(02)00041-5
   PubMed Web of Science ®Google Scholar
• Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006; (3):CD004876; PMID:16856068
   PubMedGoogle Scholar
• Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; c165(3):265-72; PMID:15710788
   PubMedGoogle Scholar
• Rizzo C, Viboud C, Montomoli E, Simonsen L, Miller MA. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 2006; 24(42–43):6468-75; PMID:16876293; http://dx.doi.org/10.1016/j.vaccine.2006.06.052
   PubMed Web of Science ®Google Scholar
• Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35(2):337-44; PMID:16368725; http://dx.doi.org/10.1093/ije/dyi274
   PubMed Web of Science ®Google Scholar
• Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009; 170(5):650-6; PMID:19625341; http://dx.doi.org/10.1093/aje/kwp173
   PubMed Web of Science ®Google Scholar
• Burckhardt AE. On intrauterine vaccination. Deutsches Archf Win Med 1879; 24:506e9
   Google Scholar
• Lichty JA, Slavin B, Bradford WL. An attempt to increase resistance to pertussis in newborn infants by immunizing their mothers during pregnancy. J Clin Invest 1938; 17(5):613-21; PMID:16694606; http://dx.doi.org/10.1172/JCI100987
   PubMedGoogle Scholar
• Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; 384(9953):1521; PMID:25037990; http://dx.doi.org/10.1016/S0140-6736(14)60686-3
   PubMed Web of Science ®Google Scholar
• Cherry J. Pertussis epidemics. N Engl J Med 2012; 367:785; PMID:22894554; http://dx.doi.org/10.1056/NEJMp1209051
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Jamieson DJ. 2009 H1N1 influenza and pregnancy. N Engl J Med 2014; 373:1373; http://dx.doi.org/10.1056/NEJMp1403496
   Web of Science ®Google Scholar
• Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 2012; 308(2):165-74; PMID:22782418; http://dx.doi.org/10.1001/jama.2012.6131
   PubMed Web of Science ®Google Scholar
• Blanchard-Rohner G, Meier S, Bel M, Combescure C, Othenin-Girard V, Swali RA, Martinez de Tejada B, Siegrist CA. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J 2013; 32(12):1374-80; PMID:24569309; http://dx.doi.org/10.1097/01.inf.0000437066.40840.c4
   PubMed Web of Science ®Google Scholar
• Steinhoff MC, MacDonald N, Pfeifer D, Muglia LJ. Influenza vaccine in pregnancy: policy and research strategies. Lancet 2014; 383(9929):1611-3; PMID:24814446; http://dx.doi.org/10.1016/S0140-6736(14)60583-3
   PubMed Web of Science ®Google Scholar
• Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014; 311(17):1760-9; PMID:24794369; http://dx.doi.org/10.1001/jama.2014.3633
   PubMed Web of Science ®Google Scholar
• Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW,; HPV-IMPACT Working Group, et al. Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008-2012. Vaccine. 2015; 33(13):1608-13; PMID:25681664; http://dx.doi.org/10.1016/j.vaccine.2015.01.084
   PubMed Web of Science ®Google Scholar
• Luna J, Plata M, Gonzalez M, Correa A, Maldonado I, Nossa C, Radley D, Vuocolo S, Haupt RM, Saah A. Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil™ in adult women. PLoS One. 2013; 8(12):e83431; PMID:24391768; http://dx.doi.org/10.1371/journal.pone.0083431
   PubMed Web of Science ®Google Scholar
• Angelo MG, Zima J, Tavares Da Silva F, Baril L, Arellano F. Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience. Pharmacoepidemiol Drug Saf 2014; 23(5):456-65; PMID:24644078; http://dx.doi.org/10.1002/pds.3593
   PubMed Web of Science ®Google Scholar
• Angelo MG, David MP, Zima J, Baril L, Dubin G, Arellano F, Struyf F. Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme. Pharmacoepidemiol Drug Saf 2014; 23(5):466-79; PMID:24644063; http://dx.doi.org/10.1002/pds.3554
   PubMed Web of Science ®Google Scholar
• Weijer C. The future of research into rotavirus vaccine. BMJ 2000; 321(7260):525-6; PMID:10968800; http://dx.doi.org/10.1136/bmj.321.7260.525
   PubMed Web of Science ®Google Scholar
• Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364(24):2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952
   PubMed Web of Science ®Google Scholar
• Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis 2013; 57(10):1427-34; PMID:23964090; http://dx.doi.org/10.1093/cid/cit520
   PubMed Web of Science ®Google Scholar
• Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med 2014; 370(6):503-12; PMID:24422676; http://dx.doi.org/10.1056/NEJMoa1303164
   PubMed Web of Science ®Google Scholar
• Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014; 370(6):513-9; PMID:24422678; http://dx.doi.org/10.1056/NEJMoa1311738
   PubMed Web of Science ®Google Scholar
• Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med 2012; 9(10):e1001330; PMID:23109915; http://dx.doi.org/10.1371/journal.pmed.1001330
   PubMed Web of Science ®Google Scholar
• Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec 2013 Feb 1; 88(5):49-64; PMID:23424730
   PubMedGoogle Scholar
• WHO. Polio vaccines: WHO position paper, January 2014–recommendations. Vaccine 2014 Jul 16; 32(33):4117-8; PMID:24768729; http://dx.doi.org/10.1016/j.vaccine.2014.04.023
   PubMed Web of Science ®Google Scholar
• McClenahan SD, Krause PR, Uhlenhaut C. Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011; 29(29–30):4745-53; PMID:21569811; http://dx.doi.org/10.1016/j.vaccine.2011.04.087
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11(10):760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011; 2(1):e00309-10; PMID:21264063; http://dx.doi.org/10.1128/mBio.00309-10
   PubMed Web of Science ®Google Scholar
• Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, and IMI-PROTECT benefit-risk participants. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies. Pharmacoepidemiol Drug Saf 2014; 23(7):667-78; PMID:24821575; http://dx.doi.org/10.1002/pds.3636
   PubMed Web of Science ®Google Scholar
• Protect Benefit Risk Website. n.d. Available from http://protectbenefitrisk.eu/
   Google Scholar
• Coplan PM, Noel RA, Levitan BS, Ferguson J, Mussen F. Development of a framework for enhancing the transparency, reproducibility and communication of the benefit-risk balance of medicines. Clin Pharmacol Ther 2011; 89(2):312-5; PMID:21160469; http://dx.doi.org/10.1038/clpt.2010.291
   PubMed Web of Science ®Google Scholar
• Mussen F, Salek S, Walker S. A quantitative approach to benefit-risk assessment of medicines – part 1: the development of a new model using multi-criteria decision analysis. Pharmacoepidemiol Drug Saf 2007; 16 Suppl 1:S2-S15; PMID:17546573; http://dx.doi.org/10.1002/pds.1435
   PubMedGoogle Scholar
• Brisson M, Van de Velde N, Boily MC. Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11. Sex Transm Infect 2011; 87(1):41-3; PMID:20924049; http://dx.doi.org/10.1136/sti.2010.044412
   PubMed Web of Science ®Google Scholar
• Advance project. n.d. Available from www.advance-vaccines.eu
   Google Scholar
• Pearce A, Marshall H, Bedford H, Lynch J. Barriers to childhood immunisation: Findings from the Longitudinal Study of Australian Children. Vaccine 2015; 33(29):3377-83; PMID:26003493; http://dx.doi.org/10.1016/j.vaccine.2015.04.089
   PubMed Web of Science ®Google Scholar
• Ruderfer D, Krilov LR. Vaccine-preventable outbreaks: still with us after all these years. Pediatr Ann 2015; 44(4):e76-81; PMID:25875983; http://dx.doi.org/10.3928/00904481-20150410-08
   PubMed Web of Science ®Google Scholar